Search | IOVS | ARVO Journals

View

Showing 1 – 4 of 4

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Real World Efficacy and Safety of Brolucizumab in Neovascular AMD: The REBEL Study

Aamir Abdul Aziz; Arshad M. Khanani; Nikolas London; Molly M. Hagen; Carl J Danzig; Amol D Kulkarni; Veeral S Sheth; Chirag D Jhaveri; David Aaron Eichenbaum; Michael Singer

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):451. doi:

ARVO Annual Meeting Abstract June 2021

Phase 1 Study of Intravitreal Gene Therapy with ADVM-022 for neovascular AMD (OPTIC Trial)

Brandon Busbee; David S Boyer; Arshad M. Khanani; Charles Clifton Wykoff; Dante Joseph Pieramici; Carl Regillo; Carl J Danzig; Brian C Joondeph; James Major; Carol Hoang; Adam Turpcu; Carol Chung; Szilard Kiss; Mehdi Gasmi; Aaron Osborne

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):352. doi:

ARVO Annual Meeting Abstract June 2021

Clinical trial versus real-world outcomes with anti-VEGF therapy for branch and central retinal vein occlusion

Carl J Danzig; Steven Blotner; Verena Steffen; Zdenka Haskova

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3174. doi:

ARVO Annual Meeting Abstract June 2020

Clinical Effects of Blocking Ang-2 and VEGF with Faricimab in the Phase 2 STAIRWAY Trial

Carl J Danzig; Hugh Lin; Pascal Guibord; David Silverman; Carlos Quezada Ruiz; Ivo Stoilov; Zdenka Haskova

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1160. doi:

Advertisement